Skip to main content
. 2024 Jan 28;16(1):9–19. doi: 10.4329/wjr.v16.i1.9

Figure 2.

Figure 2

Nomogram was developed to predict disease control rate of adenocarcinoma of the esophagogastric junction after three cycles of neoadjuvant chemotherapy with docetaxel, oxaliplatin and S-1. DCR: Disease control rate.